stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +65.8%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
Omada Health, Inc. (OMDA) P/E ratio
As of 6 November 2026, Omada Health, Inc. (OMDA) trades at a P/E ratio of 62.9×. Over the past ten years it has ranged from 0.0× (June 2026) to 357× (August 2026); the current reading is higher than 73% of that period. That is above the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 86.7× | (72.35%) |
| Jun 2026 | 314× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 5 more quarters | Free account |
Against its own ten years
Low 0.0×
High 357×
Ten-year median
0.0×
Current reading's percentile
73
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CERT Certara, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| TDOC Teladoc Health, Inc. compare | n/m |
| OMCL Omnicell, Inc. compare | 39.0× |
| HSTM HealthStream, Inc. compare | 42.0× |
| GDRX GoodRx Holdings, Inc. compare | 65.7× |
| PHR Phreesia, Inc. compare | 74.4× |
| NRC National Research Corporation compare | 87.6× |
| OMDA Omada Health, Inc. | 267× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)